Publication date: Available online 13 October 2026 Source: The Lancet Infectious Diseases Author(s): Alejandro Díez-Vidal, Pilar Vizcarra, Carlos M Oñoro-López, Cristina Marcelo-Calvo, Alejandro de Gea Grela, Beatriz Díaz-Pollán, Julio García-Rodríguez, Juana Cacho, José R Arribas
Daptomycin for enterococcal bloodstream infections and endocarditis: reconciling clinical evidence, susceptibility testing, and regulatory frameworks. // The Lancet Infectious Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S1473309926003816?dgcid=rss_sd_all
Daptomycin for enterococcal bloodstream infections and endocarditis: reconciling clinical evidence, susceptibility testing, and regulatory frameworks. The Lancet Infectious Diseases. https://www.sciencedirect.com/science/article/pii/S1473309926003816?dgcid=rss_sd_all
“Daptomycin for enterococcal bloodstream infections and endocarditis: reconciling clinical evidence, susceptibility testing, and regulatory frameworks.” The Lancet Infectious Diseases.
@article{article90933,
title = {Daptomycin for enterococcal bloodstream infections and endocarditis: reconciling clinical evidence, susceptibility testing, and regulatory frameworks},
journal = {The Lancet Infectious Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S1473309926003816?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...